Abhay Joshi
Overview
Abhay Joshi received an average of $3M in total compensation, including $415K in salary, at Revance Therapeutics from 2015 to 2021.
2021Revance TherapeuticsChief Operating Officer, President of R&D and Product Operations
2020Revance TherapeuticsChief Operating Officer
2019Revance TherapeuticsChief Operating Officer
2018Revance TherapeuticsChief Operating Officer
2017Revance TherapeuticsChief Operating Officer
2016Revance TherapeuticsChief Operating Officer
2015Revance TherapeuticsChief Operating Officer
Source: SEC filings on March 24, 2022, March 24, 2021, March 26, 2020, March 25, 2019, March 20, 2018, and March 24, 2017.
Related executives
We found 12 more executives who work or worked at Revance Therapeutics.
Mark Foley
Revance Therapeutics
Chief Executive Officer
Dustin Sjuts
Revance Therapeutics
President
Aubrey Rankin
Revance Therapeutics
Former President, Innovation & Technology
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
Dwight Moxie
Revance Therapeutics
General Counsel
L Browne
Revance Therapeutics
Chief Executive Officer
Caryn McDowell
Revance Therapeutics
General Counsel
Todd Zavodnick
Revance Therapeutics
Former Chief Commercial Officer and President, Aesthetics & Therapeutics
News
Revance Therapeutics CEO Mark Foley's 2021 pay slips 19% to $7.1M
March 24, 2022
Revance Therapeutics CEO Mark Foley's 2020 pay falls 49% to $8.8M
March 11, 2021
Revance Therapeutics CEO Mark Foley receives $17M in 2019
March 26, 2020
Revance Therapeutics CEO L Browne's 2018 pay jumps 37% to $4.7M
March 25, 2019